 |
|
|
| |
VX-135 FOR THE TREATMENT OF CHRONIC HEPATITIS - In Vitro Safety/Potency/Mechanism
|
| |
| |
Reported by Jules Levin
APASL 2013 Singapore June 6-10
C Tan, H., Deval, J., Kang, H., Moy, C., Jin, Z., Jekle, A, *Rijnbrand R., *Kieffer, T., Blatt, L.M., Chanda, S.M., Dyatkina, N., Wang, G., Zhang, Q., Symons, J.A., Beigelman, L., Smith, D.B.
Alios BioPharma Incorporated, South San Francisco, CA, USA and *Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA
|
| |
|
|
|
|
|
